Home › Funds › BRIDGEWAY FUNDS INC › Ultra-Small Company Fund
Fund family: BRIDGEWAY FUNDS INC · Filed by BRIDGEWAY FUNDS INC (CIK 916006) · SEC series S000004423
Ticker: BRUSX (C000012186)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,463 with, 2 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as BRIDGEWAY FUNDS INC’s manager page (11,064 ballot items across 5 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | BRIDGEWAY FUNDS INC | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 76.9% | 1,430 | 82.8% | 10,315 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 60.8% | 51 |
Each ballot item this fund voted is set against the votes of the other BRIDGEWAY FUNDS INC funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most BRIDGEWAY FUNDS INC funds on all 11 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 70.9% of this fund’s 1,465 such votes could be given a sector; the other 427 (29.1%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 299 | 0 | 0.0% |
| Consumer Discretionary | 226 | 0 | 0.0% |
| Health Care | 201 | 0 | 0.0% |
| Technology | 108 | 0 | 0.0% |
| Industrials | 87 | 0 | 0.0% |
| Energy | 36 | 0 | 0.0% |
| Consumer Staples | 26 | 0 | 0.0% |
| Real Estate | 24 | 0 | 0.0% |
| Telecommunications | 21 | 0 | 0.0% |
| Miscellaneous | 7 | 0 | 0.0% |
| Basic Materials | 3 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 977 | 2 |
| Audit-related | 193 | 0 |
| Say-on-Pay | 188 | 0 |
| Compensation | 79 | 0 |
| Corporate Governance | 28 | 0 |
| Capital Structure | 13 | 0 |
| Extraordinary Transactions | 13 | 0 |
| Shareholder Rights and Defenses | 5 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| SkinHealth Systems Inc. | June 10, 2026 | $7M | 11 | 0 |
| Friedman Industries, Incorporated | September 18, 2025 | $2M | 12 | 0 |
| Rimini Street, Inc. | June 3, 2026 | $2M | 5 | 0 |
| Movado Group, Inc. | June 17, 2026 | $2M | 10 | 0 |
| Fossil Group, Inc. | December 19, 2025 | $2M | 10 | 0 |
| Forum Energy Technologies, Inc. | May 8, 2026 | $2M | 6 | 0 |
| Vera Bradley, Inc. | June 4, 2026 | $1M | 9 | 0 |
| Puma Biotechnology, Inc. | June 11, 2026 | $1M | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| December 12, 2025 | Neuphoria Therapeutics Inc. | Election of two Class I directors to serve for a three-year term of office expiring at the 2028 Annual Meeting of Shareholders. While you may mark instructions with respect to any or all of the nominees, you may mark "FOR" only in respect of two nominees in total. You are permitted to vote for fewer than two nominees. If you vote "FOR" in respect of fewer than two nominees, your shares will only be voted "FOR" in respect of the nominee you have marked. If you vote "FOR" in respect of more than two nominees, your votes on Proposal 1 regarding director elections will be invalid or will not be counted. If you sign and return your proxy card and do not specify how you want your shares to be voted, they will be voted "FOR" in respect of all the Company nominees. LYNX1 Nominees: Stephen Doberstein Shareholder proposal | Withhold | For |
| December 12, 2025 | Neuphoria Therapeutics Inc. | Election of two Class I directors to serve for a three-year term of office expiring at the 2028 Annual Meeting of Shareholders. While you may mark instructions with respect to any or all of the nominees, you may mark "FOR" only in respect of two nominees in total. You are permitted to vote for fewer than two nominees. If you vote "FOR" in respect of fewer than two nominees, your shares will only be voted "FOR" in respect of the nominee you have marked. If you vote "FOR" in respect of more than two nominees, your votes on Proposal 1 regarding director elections will be invalid or will not be counted. If you sign and return your proxy card and do not specify how you want your shares to be voted, they will be voted "FOR" in respect of all the Company nominees. LYNX1 Nominees: Kimberly Smith Shareholder proposal | Withhold | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
1,496 ballot items at 209 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Ultra-Small Company Fund (BRUSX) voted at 209 shareholder meetings of 201 companies, on 1,496 ballot items in all. Where management made a recommendation, the fund followed it on 99.9% of the items and voted against it 2 times. Its most frequent area of disagreement was director elections (2 of its votes against management). It voted on 2 shareholder proposals. It voted FOR the board's own proposals less often than BRIDGEWAY FUNDS INC's funds as a whole (76.9% against 82.8%). It voted the same way as most BRIDGEWAY FUNDS INC funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BRIDGEWAY FUNDS INC’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.